 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | LUCID-MS / FSD Pharma
Enrollment open: Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants (clinicaltrials.gov) - Oct 17, 2024
P1, N=16, Recruiting, Sponsor: Quantum Biopharma
Not yet recruiting --> Recruiting
- || LUCID-MS / FSD Pharma
New P1 trial: Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants (clinicaltrials.gov) - Sep 19, 2024
P1, N=16, Not yet recruiting, Sponsor: FSD Pharma, Inc.
- || LUCID-MS / FSD Pharma
Trial completion: Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers (clinicaltrials.gov) - Aug 29, 2023
P1, N=40, Completed, Sponsor: FSD Pharma, Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| LUCID-MS / FSD Pharma
New P1 trial: Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers (clinicaltrials.gov) - Apr 20, 2023
P1, N=56, Recruiting, Sponsor: FSD Pharma, Inc.